Tag Archives | Nick Holford Prize

Identification and initial evaluation of a prototype clotting time test for enoxaparin

Background:¬†Enoxaparin is a low molecular weight heparin anticoagulant and is widely used in thromboprophylaxis for both prevention of primary thrombosis and at higher doses for treatment in patients with pulmonary embolism, deep vein thrombosis and acute coronary syndromes. Dosing of enoxaparin, like other anticoagulants, may result in bleeding following excessive doses and clot formation if […]

Continue Reading